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ABSTRACT 
Electronic medical records (EMR) contain sensitive personal information. For example, they may include details 
about infectious diseases, such as human immunodeficiency virus (HIV), or they may contain information about 
a mental illness. They may also contain other sensitive information such as medical details related to fertility 
treatments. Because EMRs are subject to confidentiality requirements, accessing and analyzing EMR databases 
is a privilege given to only a small number of individuals. Individuals who work at institutions that do not have 
access to EMR systems have no opportunity to gain hands-on experience with this valuable resource. Simulated 
medical databases are currently available; however, they are difficult to configure and are limited in their 
resemblance to real clinical databases. Generating highly accessible repositories of virtual patient EMRs while 
relying only minimally on real patient data is expected to serve as a valuable resource to a broader audience of 
medical personnel, including those who reside in underdeveloped countries. 
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INTRODUCTION 
The importance of patient privacy has been thoroughly emphasized by governmental resources such as the 
HIPAA Privacy Rule and by academia [1–3]. Numerous strategies to maintain patients’ privacy have been 
developed [4–8]; however, the medical profession is not yet able to guarantee full protection of privacy while 
providing detailed information about each patient [9]. 
Cohorts assembled from electronic medical records (EMRs) represent a powerful resource to study disease 
complications at a population level. Recent studies have demonstrated the usefulness of EMR analysis for 
discovering or confirming outcome correlations, subcategories of disease, and adverse drug events [10–16]. 
Due to confidentiality restrictions, accessing and analyzing EMR databases is a privilege given to only a small 
number of individuals. Individuals who work in institutions that do not have access to EMR systems cannot 
experiment with such valuable resources. When professors wish to teach a biomedical informatics course 
focused on EMR technology, they cannot distribute real EMR data among their students. 
Simulated medical databases [e.g., 17, 18] and open EMR platforms [19] are currently available; however, no 
confidentiality-free massive scale longitudinal EMR databases have yet been algorithmically created. Virtual 
patient repositories that bear a high degree of resemblance to real patient databases while relying only minimally 
on real patient data are expected to serve as a valuable resource for medical professionals in training, and to 
accelerate health care research and development. 
The aim of this study is to develop a novel methodology for creating virtual patient repositories. I demonstrate 
that a method entailing minimal configuration requirements can generate nonconfidential artificial EMR 
databases that could be used to practice statistical and machine-learning algorithms. I further demonstrate the 
potential broad public interest in the availability of this technology. 
MATERIALS AND METHODS 
The process of generating a virtual patient repository was based on preconfiguration of population-level and 
patient-level characteristics. First, an object-oriented program acquired a population-level configuration to 
generate patient objects. Next, the program created a clinical profile for each patient, including admissions 
associated with chief complaints and laboratory measurements. Finally, the patient objects were stored in a 
database. Following this methodology, three databases of 100, 10,000, and 100,000 virtual patients were 
created. 
Population-level configuration 
Population-level configuration specifies the number of individual records that will be generated and defines 
preconfigured values for demographic characteristics. Demographic characteristics include gender, marital 
status, major language, ethnicity, date of birth, and income level. Configuring categorical variables defines 
several potential values for the variable and the percentage of the population with the value. For example, in a 
population of n = 100,000 individuals, a potential configuration for ethnicity would be 49% white, 23% Asian, 
15% African American, and the remainder unknown. For continuous variables such as age, the population 
percentages for several ranges of date of birth are defined. For example, dates of birth in the range of 1940 to 
1950 were randomly created for 15% of the population. The configuration tables are presented in Supplemental 
Table 1(a–b). 
Generating a virtual patient repository 
Having acquired the population-level configuration, the program generated n objects each representing one 
virtual patient. Each such object is associated with distinct demographic characteristics (e.g., a certain patient 
might be an English-speaking, Asian, single woman who was born on May 17, 1982). For each such object, the 
program randomly assigns an integer representing the number of admissions associated with that patient 
throughout his or her lifetime. Each admission is associated with additional details, including randomly generated 
length of stay (in days) and start and end dates. Further, each admission is associated with laboratory 
measurements and a chief complaint randomly selected from a list of International Classification of Diseases, 
Tenth Revision, Clinical Modification (ICD-10-CM) codes. Laboratory values are based on 35 common types—
for instance, sodium levels, creatinine levels, or platelet count. The program generates for each admission 
multiple dates and times for each laboratory type; values are bounded by predefined ranges for each laboratory 
type. For example, a patient may be associated with a 3-day admission during which creatinine was measured 
6 times throughout the admission. The configuration table for laboratory types and ranges is presented in 
Supplemental Table 2. An example for the EMR lifespan of one virtual patient is presented in Figure 1. 
 
Figure 1. An example of the longitudinal EMR of a virtual patient. 
 
RESULTS 
A virtual patient repository 
Table 1 summarizes several characteristics of the largest cohort, which comprised 100,000 virtual patients. Each 
virtual patient in the cohort is associated with 1 to 10 admissions; each admission lasts from 1 to 20 days and is 
associated with a single chief complaint. All values are associated with a date and time. Each admission record 
also includes multiple measurements of common laboratory tests (see Supplemental Table 2). The number of 
admissions per patient, the length of stay per admission, and the laboratory values were randomly generated; 
however, they are sampled from predefined ranges of values. For example, a patient’s age could not exceed 95 
years old as of January 1, 2015, and a glucose measurement could only be in the range of 60–140 mg/dL. Only 
chief complaints common for both men and women were allowed in a cohort. In total, the database contained 
1.4 GB of data, representing 100,000 virtual patients associated with 361,760 admissions and 107,535,387 total 
laboratory measurements. 
Table 1. A virtual patient repository of 100,000 patients. 
 
Variable and category 
Patients 
(n = 100,000) 
Mean age as of 1/1/2015, years (SD) 57.8 (17.3) 
Gender (%) 
  Female 52.0 
Ethnicity (%) 
   White 49.0 
   Asian 23.0 
   African American 15.0 
   Unknown 13.0 
Mean number of admissions per patient, 
days (SD) 
3.6 (1.5) 
Mean length of stay (SD) 11.0 (5.2) 
% Population with length of follow-up (years) 
   0 - 9 13.1 
   10 - 15 9.3 
   > 15 77.6 
Population below poverty (%) 21.6 
Comorbidities; Prevalence (%) 
   Malignant neoplasm 41.4 
   Rheumatoid arthritis 25.6 
   Diabetes (type I or II) 24.4 
   Renal complications 17.0 
   Coronary artery disease 7.0 
Laboratory values (Mean; SD)  
   Blood urea nitrogen (mg/dL) 17.5; 7.2 
   Platelets (k/cumm) 284.9; 95.3 
   Creatinine (mg/dL) 0.9; 0.2 
   Albumin (gm/dL) 4.2; 1.0 
   Lymphocytes (%) 25; 5.8 
 
DISCUSSION 
In April 2015, the three generated cohorts were made publically available for downloading at the dedicated 
website www.emrbots.org. Since its launch, the site has been visited by more than 5,000 individuals; 
approximately 1,000 visitors registered with their full names, institution names, and e-mail addresses. The 
represented institutions included top American universities, pharmaceutical companies, and governmental 
agencies such as the Centers for Disease Control and Prevention (CDC). 
The virtual patient repositories can be instantaneously downloaded to allow users to practice algorithms on EMR-
like data with a primary objective of improving their technical skills. These skills may be used in the future when 
the individuals are granted access to real EMR. Using the repositories would not require installation of any 
software. The repositories contain raw data only and are provided as textual flat files; thus they are independent 
of any specific operating system, and may be used with a wide variety of database systems. Further, the 
repositories can be used even on low-performance computers, as they can be run on open-source software 
products—such as R and MySQL—which have minimal requirements to install. The repositories could also be 
deployed on existing open-source EMR platforms [19]. With no confidentiality restrictions, the cohorts can be 
distributed to a class of any size. For example, professors could distribute the records to a class of 100 students, 
all of whom could then use them to practice algorithms and to build models; at the end of the course, these 
students would have greater experience and capabilities, and would thus be more attractive to employers in the 
field of medical informatics. 
While the cohorts are useful for practicing machine-learning algorithms, they cannot serve as effective resources 
to assess real patient outcome scenarios (e.g., 30-day readmission prediction or disease prognosis) because 
their creation process does not take into account the complex time-dependent interactions between the factors 
associated with real patients. Developing algorithms to create virtual patient repositories that will reliably mimic 
real EMR presents is a tremendous challenge because of it necessitates approaches that will populate 
databases with a combination of linear and nonlinear associations between all medical elements, as well as with 
random associations. The algorithms required would comprise both individual-level and population-level 
assumptions and apply an intelligent functionality to assign acceptable temporal differences among all medical 
events. A virtual patient repository of nonalcoholic fatty liver disease patients, for example, would need to include 
assumptions about inverse correlations of albumin levels and sodium levels with cardiovascular disease [20], 
while virtual congestive heart failure (CHF) patients would need to be associated with a high prevalence of 
diuretic use, advanced age, and a high prevalence of associated comorbidities, such as renal failure [21]. 
A fundamental requirement is to define appropriate performance measures to assess the quality of the generated 
virtual data. Achieving a high level of resemblance between virtual and real patient data will necessitate 
development of methods to identify similarities among patients. Such methods are available; however, they focus 
either on several predefined variables [e.g., 22] based on analyzing images [e.g., 23] or on genetic similarities 
in patients [e.g., 24]. There are as yet no available methods that consider all the complex relationships among 
EMR variables. Current strategies for identifying groups of patients with similar time-dependent characteristics 
include time-series analysis methods [e.g., 25–27] and clustering techniques [e.g., 11, 28–32]. Such methods 
are based on either the supervised learning paradigm (which requires extracting manually designed features) or 
on the unsupervised learning paradigm (in which candidate variables are computationally proposed). The task 
of identifying patients with similar characteristics is multidimensional. For example, two patients might have 
similar diagnoses (e.g., both had a recent heart failure episode, or both are diabetic); however, they might vary 
in many characteristics (e.g., comorbidities or laboratory measurements). Identifying distinct groups of patients 
with similar laboratory trends, correlated with comorbidities and medications changing over time and with 
demographics, is expected to accelerate the development of algorithms that will more realistically create virtual 
patients. 
In conclusion, this study describes a novel methodology for generating confidentiality-free virtual patient 
repositories. The methodology may serve as a foundation to further generate large, longitudinal artificial EMR 
databases that highly resemble real patient records. Unlike other methods that typically obscure or shift real 
patients’ data elements, the proposed methodology is invulnerable in terms of security because it does not rely 
on real data elements pulled from an existing EMR; therefore, it is not associated with privacy concerns in regard 
to individuals’ sensitive data. 
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Supplemental Table 1. Population-level configuration 
(a) Categorical variables 
Variable Value Weight (%) 
Gender 
Male 48 
Female 52 
Marital status 
Single 32 
Married 45 
Divorced 11 
Separated 5 
Widowed 1 
Unknown 6 
Language 
English 64 
Icelandic 12 
Spanish 18 
Unknown 6 
Ethnicity 
African American 15 
Asian 23 
White 49 
Unknown 13 
 
(b) Continuous variables 
Variable 
Range 
Min Max Weight (%) 
Date of birth 
1/1/1920 1/1/1930 8 
1/1/1930 1/1/1940 9 
1/1/1940 1/1/1950 15 
1/1/1950 1/1/1960 19 
1/1/1960 1/1/1970 24 
1/1/1970 1/1/1980 15 
1/1/1980 1/1/1990 10 
Population percentage 
below poverty 
0 10 10 
10.1 20 80 
80.1 100 10 
 
Supplemental Table 2. Laboratory type and value configuration 
Laboratory title 
Minimal 
allowed value 
Maximal 
allowed value 
Units 
White blood cell count 3 12 k/cumm 
Red blood cell count 3 7 m/cumm 
Hemoglobin 10 19 gm/dl 
Hematocrit 30 55 % 
Mean corpuscular volume 70 100 fl 
Mean cell hemoglobin 22 40 pg 
Mean corpuscular hemoglobin concentration 28 40 g/dl 
Red cell distribution width 9 17 % 
Platelet count 120 450 k/cumm 
Absolute neutrophils 60 80 % 
Absolute Lymphocytes 15 35 % 
Neutrophils 1 11 k/cumm 
Lymphocytes 0.5 5 k/cumm 
Monocytes 0.08 1.2 k/cumm 
Eosinophils 0.08 0.6 k/cumm 
Basophils 0 0.22 k/cumm 
Sodium 125 155 mmol/L 
Potassium 3 6 mmol/L 
Chloride 90 115 mmol/L 
Carbon dioxide 18 36 mmol/L 
Anion gap 3 18 mmol/L 
Glucose 60 140 mg/dL 
Blood urea nitrogen 5 30 mg/dL 
Creatinine 0.5 1.2 mg/dL 
Total protein 5 10 gm/dL 
Albumin 2.5 6 gm/dL 
Calcium 7 12 mg/dL 
Total bilirubin 0 1.2 mg/dL 
Aspartate aminotransferase 12 42 U/L 
Serum glutamic pyruvic transaminase 15 75 U/L 
Alkaline phosphatase 40 150 U/L 
Urine specific gravity 1.014 1.028 no unit 
Urine pH 4.5 7.5 no unit 
Urine red blood cells 0 3.5 rbc/hpf 
Urine white blood cells 0 6 wbc/hpf 
 
 
 
